Navegar

Colección

Datos Estadísticas

Lista de

Lung Neoplasms
31
"Antitumor effectiveness of a combined therapy with a new cucurbitacin B derivative and paclitaxel on a human lung cancer xenograft model" (2017) Marostica, L.L.;de Barros, A.L.B.;Oliveira, J. (...)Simões, C.M.O. Toxicology and Applied Pharmacology. 329:272-281
"Antitumor effectiveness of a combined therapy with a new cucurbitacin B derivative and paclitaxel on a human lung cancer xenograft model" (2017) Marostica, L.L.;de Barros, A.L.B.;Oliveira, J. (...)Simões, C.M.O. Toxicology and Applied Pharmacology. 329:272-281
"Cytotoxic effects of natural and semisynthetic cucurbitacins on lung cancer cell line A549" (2016) Silva, I.T.;Geller, F.C.;Persich, L. (...)Simões, C.M.O. Investigational New Drugs. 34(2):139-148
"Cytotoxic effects of natural and semisynthetic cucurbitacins on lung cancer cell line A549" (2016) Silva, I.T.;Geller, F.C.;Persich, L. (...)Simões, C.M.O. Investigational New Drugs. 34(2):139-148
"In vitro and in vivo antitumor activity of a novel semisynthetic derivative of cucurbitacin B" (2015) Silva, I.T.;Carvalho, A.;Lang, K.L. (...)Ludwig, S. PLoS ONE. 10(2)
"In vitro and in vivo antitumor activity of a novel semisynthetic derivative of cucurbitacin B" (2015) Silva, I.T.;Carvalho, A.;Lang, K.L. (...)Ludwig, S. PLoS ONE. 10(2)
"Synergistic Antiproliferative Effects of a New Cucurbitacin B Derivative and Chemotherapy Drugs on Lung Cancer Cell Line A549" (2015) Marostica, L.L.;Silva, I.T.;Kratz, J.M. (...)Simões, C.M.O. Chemical Research in Toxicology. 28(10):1949-1960
"Synergistic Antiproliferative Effects of a New Cucurbitacin B Derivative and Chemotherapy Drugs on Lung Cancer Cell Line A549" (2015) Marostica, L.L.;Silva, I.T.;Kratz, J.M. (...)Simões, C.M.O. Chemical Research in Toxicology. 28(10):1949-1960
"Polyoxygenated steroids from the octocoral leptogorgia punicea and in vitro evaluation of their cytotoxic activity" (2014) Moritz, M.I.G.;Marostica, L.L.;Bianco, É.M. (...)Schenkel, E.P. Marine Drugs. 12(12):5864-5880
"Polyoxygenated steroids from the octocoral leptogorgia punicea and in vitro evaluation of their cytotoxic activity" (2014) Moritz, M.I.G.;Marostica, L.L.;Bianco, É.M. (...)Schenkel, E.P. Marine Drugs. 12(12):5864-5880
"Anti-tumor effect of SLPI on mammary but not colon tumor growth" (2013) Amiano, N.O.;Costa, M.J.;Reiteri, R.M. (...)Chuluyan, H.E. Journal of Cellular Physiology. 228(2):469-475
"Behaviour of mesenchymal stem cells from bone marrow of untreated advanced breast and lung cancer patients without bone osteolytic metastasis" (2013) Fernández Vallone, V.B.;Hofer, E.L.;Choi, H. (...)Chasseing, N.A. Clinical and Experimental Metastasis. 30(3):317-332
"Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease" (2013) Dalotto-Moreno, T.;Croci, D.O.;Cerliani, J.P. (...)Salatino, M. Cancer Research. 73(3):1107-1117
"Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data" (2012) Degese, M.S.;Mendizabal, J.E.;Gandini, N.A. (...)Facchinetti, M.M. Lung Cancer. 77(1):168-175
"Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments" (2012) Soldati, R.;Berger, E.;Zenclussen, A.C. (...)Fest, S. International Journal of Cancer. 131(5):1131-1141
"Cytotoxic tirucallane triterpenoids from Melia azedarach fruits" (2010) Ntalli, N.G.;Cottiglia, F.;Bueno, C.A. (...)Caboni, P. Molecules. 15(9):5866-5877
"Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance" (2010) Carlini, M.J.;Dalurzo, M.C.L.;Lastiri, J.M. (...)Lauría de Cidre, L.S. Human Pathology. 41(5):697-705
"Emerging pharmacotherapy of tinnitus" (2009) Langguth, B.; Salvi, R.; Elgoyhen, A.B. Expert Opinion on Emerging Drugs. 14(4):687-702
"Tumor necrosis factor-alfa production by monocytes from lung and colorectal cancer patients" (2001) Trejo, Y.G.;Bordenave, R.H.;Beviacqua, M. (...)Rumi, L.S. Journal of Experimental and Clinical Cancer Research. 20(1):71-73
"Paraneoplastic neuropathy with positive anti-Hu " (1998) Parera, I.C.;Fischman, D.;Paz, L. (...)Muchnik, S. Medicina. 58(2):197-201
"Induccion de adenocarcinomas mamarios por progestagenos en ratones BALB/c: Progresion del tumor hormono-dependiente al autonomo" (1997) Lanari, C.;Montecchia, M.F.;Pazos, P. (...)Mounolo, A.A. Medicina. 57(SUPPL 2):55-69
"Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability" (1996) Guerra, F.K.;Eijan, A.M.;Puricelli, L. (...)Elizalde, P.V. International Journal of Cancer. 65(6):812-820
"Chemiluminescence production by neutrophils and immune complex levels in cancer patients" (1993) Chasseing, N.A.;Barañao, R.I.;Fernández, O. (...)Rumi, L.S. Cancer Investigation. 11(5):517-522
"Differentiating effect of l-tyrosine on the human melanoma cell line IIB-MEL-J" (1990) Guerra, L.; Bover, L.; Mordoh, J. Experimental Cell Research. 188(1):61-65
"Correlation between urokinase-type plasminogen activator production and the metastasizing ability of two murine mammary adenocarcinomas" (1988) Pereyra-Alfonso, S.; Haedo, A.; de Kier Joffe, E.B. International Journal of Cancer. 42(1):59-63